Herbalife (HLF) Expected to Post Quarterly Earnings on Wednesday

Herbalife (NYSE:HLF) is projected to post its Q2 2026 results after the market closes on Wednesday, August 5th. Analysts expect Herbalife to announce earnings of $0.5360 per share and revenue of $1.3076 billion for the quarter. Parties are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, August 5, 2026 at 5:30 PM ET.

Herbalife (NYSE:HLF) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.61 by $0.03. The firm had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.30 billion. Herbalife had a net margin of 4.67% and a negative return on equity of 41.47%. The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter last year, the firm posted $0.59 EPS. On average, analysts expect Herbalife to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Herbalife Stock Down 0.1%

Shares of Herbalife stock opened at $12.41 on Monday. Herbalife has a twelve month low of $7.56 and a twelve month high of $20.40. The company’s 50 day moving average is $12.25 and its 200 day moving average is $14.64. The company has a market cap of $1.29 billion, a price-to-earnings ratio of 5.44, a price-to-earnings-growth ratio of 0.68 and a beta of 0.87.

Insider Transactions at Herbalife

In other news, insider Frank Lamberti sold 134,982 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $13.50, for a total transaction of $1,822,257.00. Following the transaction, the insider owned 36,624 shares of the company’s stock, valued at approximately $494,424. The trade was a 78.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, COO Troy Hicks sold 10,000 shares of the firm’s stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $12.32, for a total value of $123,200.00. Following the completion of the sale, the chief operating officer owned 9,706 shares of the company’s stock, valued at approximately $119,577.92. This represents a 50.75% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 191,296 shares of company stock worth $2,551,678. Insiders own 5.13% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of HLF. Manatuck Hill Partners LLC lifted its stake in shares of Herbalife by 122.2% during the 3rd quarter. Manatuck Hill Partners LLC now owns 1,000,000 shares of the company’s stock worth $8,440,000 after purchasing an additional 550,000 shares during the last quarter. Invesco Ltd. raised its holdings in Herbalife by 60.5% in the third quarter. Invesco Ltd. now owns 763,857 shares of the company’s stock worth $6,447,000 after purchasing an additional 287,880 shares in the last quarter. UBS Group AG lifted its position in shares of Herbalife by 74.3% during the third quarter. UBS Group AG now owns 658,654 shares of the company’s stock valued at $5,559,000 after buying an additional 280,870 shares during the last quarter. Solel Partners LP grew its position in shares of Herbalife by 18.7% in the 2nd quarter. Solel Partners LP now owns 1,669,405 shares of the company’s stock worth $14,390,000 after buying an additional 262,614 shares during the last quarter. Finally, Counterpoint Mutual Funds LLC bought a new position in shares of Herbalife during the 4th quarter worth approximately $3,368,000.

Wall Street Analyst Weigh In

HLF has been the subject of a number of recent research reports. Royal Bank Of Canada cut their price target on Herbalife from $17.00 to $16.00 and set a “sector perform” rating for the company in a research note on Tuesday, April 28th. Zacks Research cut Herbalife from a “strong-buy” rating to a “hold” rating in a report on Monday, April 20th. Wall Street Zen cut Herbalife from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 18th. Weiss Ratings lowered shares of Herbalife from a “hold (c+)” rating to a “hold (c)” rating in a report on Friday, July 24th. Finally, Mizuho set a $17.00 price objective on shares of Herbalife in a research note on Monday, May 4th. Three equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $17.80.

About Herbalife

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.